Elite Pharmaceuticals (ELTP) Interest & Investment Income (2016 - 2026)
Elite Pharmaceuticals' Interest & Investment Income was $166,117 in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with $4,542 a year earlier and up 44.7% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Interest & Investment Income (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Elite Pharmaceuticals' Interest & Investment Income was $369,432 through Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it was $207,857, up 892.4% from FY2025.
- Interest & Investment Income has now increased for three consecutive fiscal years, with a five-year compound annual growth rate of 232.2% (FY2021 to FY2026).
- In earlier fiscal years, Interest & Investment Income was $20,944 in FY2025 (+0.1%), $20,918 in FY2024 (+180.7%), $7,453 in FY2023 and $126.00 in FY2022 (-75.5%).
- The fiscal Q1 2027 figure marks the highest quarterly Interest & Investment Income in data going back to fiscal Q1 2017.
- The best year-over-year quarter for Interest & Investment Income over five years was fiscal Q1 2023 (growth of 207.1%); the worst was fiscal Q3 2022 (a decline of 86.7%).
- Per Business Quant data, ELTP's Interest & Investment Income in the three fiscal quarters before Q1 2027 was $114,791 (Q4 2026), $83,602 (Q3 2026) and $4,922 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Elite Pharmaceuticals | 269.28 Mn | 150.96 Mn | 13.51 Mn | 166,117.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 166,117.00 |
| Mar 31, 2026 | 114,791.00 |
| Dec 31, 2025 | 83,602.00 |
| Sep 30, 2025 | 4,922.00 |
| Jun 30, 2025 | 4,542.00 |
| Mar 31, 2025 | 4,560.00 |
| Dec 31, 2024 | 5,092.00 |
| Sep 30, 2024 | 5,902.00 |
| Jun 30, 2024 | 5,390.00 |
| Mar 31, 2024 | 4,833.00 |
| Dec 31, 2023 | 5,249.00 |
| Sep 30, 2023 | 7,320.00 |
| Jun 30, 2023 | 3,516.00 |
| Mar 31, 2023 | 7,266.00 |
| Dec 31, 2022 | 15.00 |
| Sep 30, 2022 | 43.00 |
| Jun 30, 2022 | 129.00 |
| Mar 31, 2022 | 49.00 |
| Dec 31, 2021 | 13.00 |
| Sep 30, 2021 | 21.00 |
API Access
Elite Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();